Clinical Trials Browser

NETWORK × Endometrial Neoplasms × lenvatinib × Clear all

NCT03005015 2016-12-29

Lenvatinib in Second Line Endometrial Carcinoma

Phase 2 Withdrawn

Endometrial Neoplasms